Platinum Resistant Ovarian Cance clinical trials

Explore recruiting platinum resistant ovarian cance clinical trials.

Also recruiting in Europe

Platinum Resistant Ovarian Cance trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 1/2 Dose-Escalation and Dose-Expansion Study of ZN-c3 in Combination with Niraparib and ZN-c3 Monotherapy in Subjects with Platinum-resistant Ovarian Cancer.

France

Human Pharmacology (Phase I)- Other EU CTIS Study details

Platinum Resistant Ovarian Cance trials by city

Platinum Resistant Ovarian Cance in Toronto Platinum Resistant Ovarian Cance in Vancouver Platinum Resistant Ovarian Cance in Montreal Platinum Resistant Ovarian Cance in Calgary Platinum Resistant Ovarian Cance in Edmonton Platinum Resistant Ovarian Cance in Ottawa Platinum Resistant Ovarian Cance in Winnipeg Platinum Resistant Ovarian Cance in Quebec City Platinum Resistant Ovarian Cance in Hamilton Platinum Resistant Ovarian Cance in Kitchener Platinum Resistant Ovarian Cance in London Platinum Resistant Ovarian Cance in Halifax Platinum Resistant Ovarian Cance in New York Platinum Resistant Ovarian Cance in Los Angeles Platinum Resistant Ovarian Cance in Chicago Platinum Resistant Ovarian Cance in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease